Precision Biosciences (DTIL) Total Liabilities (2018 - 2025)
Historic Total Liabilities for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $76.9 million.
- Precision Biosciences' Total Liabilities fell 1302.83% to $76.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.9 million, marking a year-over-year decrease of 1302.83%. This contributed to the annual value of $80.0 million for FY2024, which is 4323.37% down from last year.
- Precision Biosciences' Total Liabilities amounted to $76.9 million in Q3 2025, which was down 1302.83% from $74.9 million recorded in Q2 2025.
- Precision Biosciences' 5-year Total Liabilities high stood at $203.5 million for Q1 2021, and its period low was $74.9 million during Q2 2025.
- Over the past 5 years, Precision Biosciences' median Total Liabilities value was $129.6 million (recorded in 2021), while the average stood at $130.1 million.
- In the last 5 years, Precision Biosciences' Total Liabilities soared by 10520.13% in 2021 and then tumbled by 4911.44% in 2025.
- Precision Biosciences' Total Liabilities (Quarter) stood at $120.3 million in 2021, then surged by 47.71% to $177.7 million in 2022, then decreased by 20.71% to $140.9 million in 2023, then crashed by 43.23% to $80.0 million in 2024, then dropped by 3.9% to $76.9 million in 2025.
- Its Total Liabilities was $76.9 million in Q3 2025, compared to $74.9 million in Q2 2025 and $75.1 million in Q1 2025.